Recall
FDAHealthJanuary 29, 2025

Glenmark Pharmaceuticals Inc., USA — Atomoxetine Capsules, USP, 100 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-271-30.

⚠️ CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
January 29, 2025

Nationwide within the U.S

What's affected?

Product
Atomoxetine Capsules, USP, 100 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-271-30.
UPC
0368462265307
Lot code
19234955

Additional details

Lot Numbers: 19234955, 19234956, Exp.: 11/2025; 19240971, Exp.: 2/2026; 19241864, Exp.: 4/2026.

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 39,168 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.